Table 1 Clinical and metabolic features of the studied population
From: Lack of awareness of liver organ damage in patients with type 2 diabetes
| Characteristic | Entire population (n = 825) |
|---|---|
| Male participants (%) | 52.9 ± 3.26 |
| Age (years) | 60.6 ± 1.05 |
| Diabetes duration (years) | 10.1 ± 1.03 |
| BMI (Kg/m2) | 33.3 ± 0.53 |
| Obesity (%) | 64.1 ± 2.96 |
| Waist circumference (cm) | 111.9 ± 1.05 |
| Current smoke (%) | 27.0 ± 4.02 |
| Ethnicity (%) | |
| Non-Hispanic white | 56.9 ± 3.30 |
| Non-Hispanic black | 13.3 ± 2.44 |
| Hispanics | 16.1 ± 1.94 |
| Asian | 7.5 ± 1.24 |
| Others | 6.2 ± 1.10 |
| Hepatitis B (%) | 1.00 ± 0.03 |
| Hepatitis C (%) | 0.4 ± 0.21 |
| Laboratory features | |
| HbA1c (%, mmol/mol) | 7.2, 55.2 ± 0.46 |
| AST (U/l) | 22.2 ± 0.57 |
| ALT (U/l) | 24.8 ± 0.91 |
| GGT (U/l) | 36.9 ± 1.99 |
| Platelet count (× 109/L) | 241.9 ± 5.44 |
| Albumin (g/l) | 39 ± 0.2 |
| Total Cholesterol (mmol/l) | 4.7 ± 0.07 |
| HDL-cholesterol (mmol/l) | 1.2 ± 0.02 |
| Triglycerides (mmol/l) | 2.3 ± 0.13 |
| LDL-cholesterol (mmol/l) | 2.4 ± 0.06 |